Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,182.00
-11.00 (-0.50%)
At close: Dec 29, 2025
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 905.28 billion as of December 29, 2025. Its market cap has decreased by -14.39% in one year.
Market Cap
905.28B
Enterprise Value
956.41B
Revenue
135.46B
Ranking
n/a
PE Ratio
51.51
Stock Price
2,182.00
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 905.28B, an increase of 58.89%. That is a compound annual growth rate of 19.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 905.28B | -23.82% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.13T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 917.23B |
| Aurobindo Pharma | 700.56B |
| Fortis Healthcare | 681.27B |
| Alkem Laboratories | 661.79B |